Use of autologous pregnancy plasma to treat a flare of juvenile rheumatoid arthritis: Case report and literature review
β Scribed by Daniel J. Wallace; Dennis Goldfinger; James R. Klinenberg
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 255 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
β¦ Synopsis
A patient with juvenile rheumatoid arthritis whose disease was in remission during pregnancy underwent thirdtrimester plasmaphereses. The stored plasma was returned to her 1 year postpartum, when the disease flared. without beneficial results. The literature on the use of blood products in rheumatoid arthritis and pregnancy is rcviewed.
π SIMILAR VOLUMES
A patient being treated for sickle cell disease with hydroxyurea (1 g/d) conceived, and drug treatment was discontinued at nine weeks gestational age. The pregnancy and delivery were complicated by vaso-oclusive crises. A healthy male infant was born at 39 weeks with no evidence of congenital malfor
## Abstract Idiopathic thrombotic thrombocytopenic purpura (TTP) is caused by the production of autoantibodies against the Von Willebrand factor cleaving enzyme. This provides a rationale for the use of rituximab in this disease. We report a retrospective review of 12 patients treated with rituxima
## Abstract Heparinβinduced thrombocytopenia (HIT), which is characterized by thrombocytopenia and potentially serious thromboses, may develop in patients exposed to heparin anticoagulation. HIT is caused by antibodies to the heparin/platelet factor 4 (PF4) complex. Management of HIT involves disco